Next-Generation Cancer Magnetic Resonance Imaging With Tumor-Targeted Alkylphosphocholine Metal Analogs
Conclusions
We have introduced a new macrocyclic cancer-targeted Gd chelate that achieves broad-spectrum tumor uptake and prolonged retention. Furthermore, we have demonstrated in vivo stability of Gd-NM600 by ultrahigh resolution MS tissue imaging. A tumor-targeted contrast agent coupled with the enhanced imaging resolution of MRI relative to positron emission tomography may transform oncologic imaging.
Source: Investigative Radiology - Category: Radiology Tags: Special Issue 2022-Contrast Media Source Type: research
More News: Cancer | Cancer & Oncology | Chemistry | Clinical Trials | MRI Scan | PET Scan | Radiology | Study